Friday, October 29, 2021

ViewPlus VP Rogue Braille Embosser with Tactile Graphics and CRISPR Used For Gene Editing To Treat Leber Congenital Amaurosis

VP Rogue (ViewPlus Technologies - Corvallis, OR)

Dr. Mark Pennesi (Casey Eye Institute, Oregon Health and Science University, Portland, OR)

Dan Gardner, CEO of ViewPlus Technologies, in Corvallis, Oregon, discusses the VP Rogue Sheet and Trac, which are braille embossers, capable of producing high resolution tactile graphics.

Then, Dr. Mark Pennesi, professor of ophthalmology, at Casey Eye Institute, at Oregon Health and Science University, in Portland, explains how a gene editing technique called, CRISPR, can be used to treat Leber Congenital Amaurosis.


10/31/2021 (Click Image Below) 

Thursday, October 21, 2021

School-Based Vision For Baltimore Program and Treating Dry Eye with Eye Drops Derived From Corneal Epithelial Stem Cells

Dr. Megan Collins (Johns Hopkins University Wilmer Eye Institute - Baltimore, MD)

Dr. Hiranmoy Das (Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy - Amarillo, TX)


Dr. Megan Collins, an assistant professor of ophthalmology, at Johns Hopkins University Wilmer Eye Institute, discusses Vision for Baltimore, a city-wide program to expand school-based vision services for all students in grades pre-kindergarten through eighth grade in Baltimore City public schools. 

Then, Dr. Hiranmoy Das, a professor of pharmaceutical sciences, at Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy in Amarillo, explains how eye drops can be derived from corneal epithelial stem cells to treat severe dry eye disease.

10/24/2021 Podcast (Click Image Below)